Search Login Register
Osteosarcoma
(Osteogenic Sarcoma)
Summary
Description:
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Also Known As:
Osteogenic Sarcoma; Osteosarcomas; Osteosarcoma Tumor; Osteogenic Sarcomas; Osteosarcoma Tumors Show All >>
Networked: 9412
relevant articles (483 outcomes,
1680 trials/studies)
for this Disease
Key Drugs and Agents for Osteosarcoma
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Doxorubicin (Adriamycin)
:
34 outcomes 88 studies in 454 results
:
FDA 12
Generic
-
Cisplatin (Platino)
:
31 outcomes 89 studies in 403 results
:
FDA 6
Generic
-
Methotrexate (Mexate)
:
26 outcomes 64 studies in 451 results
:
FDA 8
Generic
-
Ifosfamide
:
22 outcomes 42 studies in 141 results
:
FDA 7
Generic
-
Carboplatin (JM8)
:
8 outcomes 12 studies in 50 results
:
FDA 29
Generic
-
muramylNAc-Ala-isoGln-Lys-tripeptide-PE
:
7 outcomes 14 studies in 26 results
: IBA
-
Liposomes (Liposome)
:
6 outcomes 18 studies in 54 results
: IBA
-
gemcitabine
:
6 outcomes 8 studies in 33 results
:
FDA 7
-
Leucovorin (Folinic Acid)
:
6 outcomes 6 studies in 73 results
:
FDA 6
-
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
:
5 outcomes 35 studies in 127 results
: IBA
Show All >>
Diseases Related to Osteosarcoma
-
Neoplasms (Cancer)
-
Neoplasm Metastasis (Metastasis)
-
Sarcoma (Soft Tissue Sarcoma)
-
Ewing's Sarcoma (Sarcoma, Ewing)
-
Chondrosarcoma
Show All >>
Key Therapies for Osteosarcoma
Efficacy Chart >>
-
Drug Therapy (Chemotherapy)
:
214 outcomes 251 studies in 1657 results
-
Adjuvant Chemotherapy
:
31 outcomes 40 studies in 248 results
-
Limb Salvage
:
15 outcomes 21 studies in 170 results
-
Amputation
:
12 outcomes 20 studies in 259 results
-
Heterologous Transplantation (Xenotransplantation)
:
11 outcomes 20 studies in 218 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.